Legislation
- Title
- Business Regulation - Marketing Synthetic Drugs - Penalties
- Sponsored by
- Senator Muse
- Status
- In the Senate - Unfavorable Report by Finance
- Analysis
- Fiscal and Policy Note
Synopsis
Prohibiting a person issued a specified license from possessing, providing, distributing, displaying, selling, or marketing a specified synthetic drug with the intent that it be used as a recreational drug; providing specified factors to be treated as indicia that a product is a specified synthetic drug; providing that specified proof is prima facie evidence of a violation of the Act; requiring that a specified person must permit the Comptroller to inspect specified records and products; etc.
Committees
- Original:
- Finance Click to view Recorded Media
Details
History
Toggle History Dropdown
Documents
Toggle Documents Dropdown
Date Posted | Document Name |
---|---|
2/09/2016 | Text - First - Business Regulation - Marketing Synthetic Drugs - Penalties |
3/23/2016 | Vote - Senate - Committee - Finance |
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
17-20B-01 through 17-20B-06 )
Last Updated: 2/3/2020 2:30 PM